Iron Supplementation (Paediatric)
Brand names: Sytron (sodium feredetate), Ferrous Sulfate, Niferex (iron polysaccharide)
Oral iron supplements are used in children to prevent and treat iron-deficiency anaemia, including in preterm infants and children with dietary or absorptive deficiency.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Supplemental iron provides the elemental iron required for haemoglobin synthesis, replenishing depleted stores and restoring effective erythropoiesis.
Prescribing in practice
- Iron is a leading cause of accidental childhood poisoning, so emphasise that preparations be stored safely out of reach of children and given strictly as prescribed.
- Iron impairs absorption of certain medicines and is itself reduced by milk, antacids and tea, so attention to timing and co-administered drugs is needed.
- Choose the preparation and dose using a children's formulary, accounting for the elemental iron content of the salt.
Monitoring
Monitor haemoglobin and reticulocyte response with iron indices such as ferritin, and review adherence if the expected response is not achieved.
Counselling the patient
- Keep iron preparations well out of reach of children, as overdose can be very dangerous.
- Liquid iron can stain teeth, so give with a straw or beaker and rinse the mouth afterwards.
- Black stools are expected and harmless; give with vitamin C-rich juice rather than milk to aid absorption.
Evidence & guidelines
Iron supplementation is a long-established, guideline-endorsed treatment for childhood iron-deficiency anaemia, with preterm infants recognised as being at particular risk of deficiency.
Reference: NICE NG24 (Iron Deficiency Anaemia); WHO Guidelines on Iron Supplementation; BSH Iron Deficiency Anaemia Guidelines 2021; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.